Literature DB >> 16772015

[Human cryptosporidiosis and Cryptosporidium spp. in Haiti].

Christian P Raccurt1, Philippe Brasseur, Rose I Verdier, Xunde Li, Etna Eyma, Christine Pannier Stockman, Patrice Agnamey, Karine Guyot, Anne Totet, Bernard Liautaud, Gilles Nevez, Eduardo Dei-Cas, Jean W Pape.   

Abstract

Contamination by water-born infectious diseases is closely linked to urban slums conditions such as overcrowding and high level of faecal pollution by animal and human excreta. In this environment, cryptosporidiosis is a major cause of acute diarrhoea in children and chronic persistent diarrhoea in AIDS patients, resulting in increased morbidity and mortality in both populations. The aims of this study conducted in Port-au-Prince, Haiti were to: (i) determine the frequency of Cryptosporidium infection in two populations of patients with diarrhoea, children and AIDS patients, and the existence of Cryptosporidium carriage in healthy adults living in close contact with them; (ii) identify by molecular genotyping the Cryptosporidium species involved; and (iii) evaluate the viability of Cryptosporidium oocysts isolated from human stools. From January 2000 to January 2001, 158 of 1529 diarrhoea stool samples collected from 93 patients with diarrhoea, 57 adults followed at Centres GHESKIO and 36 children admitted at the University Hospital in Port-au-Prince contained Cryptosporidium oocysts (10.3%). The majority of adult patients (98%) were HIV-infected whereas the majority of children (81%) tested negative for HIV. Cryptosporidium was documented in only 1/102 healthy persons living in contact with Cryptosporidium infected patients and infection was with the same genotype as that of the contact patient. Among the 69 Cryptosporidium isolates studied for genotyping, three species were identified: C. hominis (59%), C. parvum (38%) and C. felis (3%). The two C. felis cases are the first reported from AIDS patients in the Caribbean. Most of the children regardless of their HIV status were infected with C. hominis (72%), whereas AIDS patients were more likely to be infected by either human or animal genotypes. These data confirm that immunocompromised individuals are susceptible to a wide range of Cryptosporidium spp. Viability of Cryptosporidium oocysts were determined in an experimental mouse model for 17/18 specimen studied including in 12/13 C. hominis, 4/4 C. parvum and 1/1 C. felis. Infectivity in newborn mice was found to be dose-dependent and more effective with C. parvum than the other two genotypes. Cryptosporidiosis remains a frequent hazard for both AIDS patients and young children in Haiti because of poor hygiene, particularly contaminated water and overcrowded conditions associated with urban slums.

Entities:  

Mesh:

Year:  2006        PMID: 16772015     DOI: 10.1111/j.1365-3156.2006.01631.x

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  9 in total

1.  Cryptosporidiosis in HIV/AIDS patients in Kenya: clinical features, epidemiology, molecular characterization and antibody responses.

Authors:  Jane W Wanyiri; Henry Kanyi; Samuel Maina; David E Wang; Aaron Steen; Paul Ngugi; Timothy Kamau; Tabitha Waithera; Roberta O'Connor; Kimani Gachuhi; Claire N Wamae; Mkaya Mwamburi; Honorine D Ward
Journal:  Am J Trop Med Hyg       Date:  2014-05-27       Impact factor: 2.345

2.  Cloning and characterization of the acidic ribosomal protein P2 of Cryptosporidium parvum, a new 17-kilodalton antigen.

Authors:  Jeffrey W Priest; James P Kwon; Joel M Montgomery; Caryn Bern; Delynn M Moss; Amanda R Freeman; Cara C Jones; Michael J Arrowood; Kimberly Y Won; Patrick J Lammie; Robert H Gilman; Jan R Mead
Journal:  Clin Vaccine Immunol       Date:  2010-04-21

3.  Risks of recreational exposure to waterborne pathogens among persons with HIV/AIDS in Baltimore, Maryland.

Authors:  Cynthia C McOliver; Hanna B Lemerman; Ellen K Silbergeld; Richard D Moore; Thaddeus K Graczyk
Journal:  Am J Public Health       Date:  2009-04-16       Impact factor: 9.308

4.  Global distribution, public health and clinical impact of the protozoan pathogen cryptosporidium.

Authors:  Lorenza Putignani; Donato Menichella
Journal:  Interdiscip Perspect Infect Dis       Date:  2010-07-14

5.  Epidemiology and molecular relationships of Cryptosporidium spp. in people, primates, and livestock from Western Uganda.

Authors:  Stephanie J Salyer; Thomas R Gillespie; Innocent B Rwego; Colin A Chapman; Tony L Goldberg
Journal:  PLoS Negl Trop Dis       Date:  2012-04-10

6.  Cryptosporidiosis in Haiti: surprisingly low level of species diversity revealed by molecular characterization of Cryptosporidium oocysts from surface water and groundwater.

Authors:  Céline Damiani; Ketty Balthazard-Accou; Elmyre Clervil; Aïssata Diallo; Cécilia Da Costa; Evens Emmanuel; Anne Totet; Patrice Agnamey
Journal:  Parasite       Date:  2013-11-20       Impact factor: 3.000

7.  Cryptosporidium species and subtypes and clinical manifestations in children, Peru.

Authors:  Vitaliano A Cama; Caryn Bern; Jacqueline Roberts; Lilia Cabrera; Charles R Sterling; Ynes Ortega; Robert H Gilman; Lihua Xiao
Journal:  Emerg Infect Dis       Date:  2008-10       Impact factor: 6.883

8.  Unique Cryptosporidium population in HIV-infected persons, Jamaica.

Authors:  Wangeci Gatei; Donnett Barrett; John F Lindo; Denise Eldemire-Shearer; Vitaliano Cama; Lihua Xiao
Journal:  Emerg Infect Dis       Date:  2008-05       Impact factor: 6.883

9.  Cryptosporidium species subtypes and associated clinical manifestations in Indian patients.

Authors:  Shehla Khalil; Bijay Ranjan Mirdha; Ashutosh Panda; Yogita Singh; Govind Makharia; Jaishree Paul
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2017
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.